Silvia Di Agostino
Overview
Explore the profile of Silvia Di Agostino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1837
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parrotta E, Lucchino V, Zannino C, Valente D, Scalise S, Bressan D, et al.
Ann Neurol
. 2025 Jan;
PMID: 39876539
Objective: Progressive Supranuclear Palsy (PSP) is a severe neurodegenerative disease characterized by tangles of hyperphosphorylated tau protein and tufted astrocytes. Developing treatments for PSP is challenging due to the lack...
2.
Bruno T, Catena V, Blandino G, Fanciulli M, Di Agostino S
J Exp Clin Cancer Res
. 2024 Dec;
43(1):322.
PMID: 39695699
Multiple myeloma (MM), a hematologic malignancy characterized by the clonal expansion of plasma cells within the bone marrow, is associated with severe health complications, including osteolytic bone lesions that significantly...
3.
Valenti F, Ganci F, Sacconi A, Lo Sardo F, DAndrea M, Sanguineti G, et al.
J Mol Med (Berl)
. 2024 Oct;
102(12):1485-1501.
PMID: 39480521
Polo-like kinase 2 (Plk2) belongs to a family of serine/threonine kinases, and it is involved in tumorigenesis of diverse kind of tissues. We previously reported that Plk2 gene was a...
4.
Bossio S, Urlandini L, Perri A, Conforti F, Aversa A, Di Agostino S, et al.
Life (Basel)
. 2024 Sep;
14(9).
PMID: 39337878
Prostate cancer (PCa) is the third highest cause of cancer death in men. PCa is a very heterogeneous tumor form in terms of grade, phenotypes, and genetics, often accompanied by...
5.
Rago V, Conforti F, La Russa D, Antonucci G, Urlandini L, Lofaro D, et al.
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791274
Numerous animal models have demonstrated that caloric restriction (CR) is an excellent tool to delay aging and increase the quality of life, likely because it counteracts age-induced oxidative stress and...
6.
Bruno T, Catena V, Corleone G, Cortile C, Cappelletto M, Bellei B, et al.
Leukemia
. 2024 Feb;
38(4):877-882.
PMID: 38368441
No abstract available.
7.
Rago V, Bossio S, Lofaro D, Perri A, Di Agostino S
Life (Basel)
. 2024 Jan;
14(1).
PMID: 38255667
Cancer has been described as a risk factor for greater susceptibility to SARS-CoV-2 infection and severe COVID-19, mainly for patients with metastatic disease. Conversely, to that reported for most solid...
8.
Rago V, Perri A, Di Agostino S
Biomedicines
. 2023 Oct;
11(10).
PMID: 37893116
One of the major goals in the advancement of basic cancer research focuses on the development of new anticancer therapies. To understand the molecular mechanisms of cancer progression, acquired drug...
9.
Di Agostino S, Canu V, Donzelli S, Pulito C, Sacconi A, Ganci F, et al.
Cell Death Dis
. 2023 Aug;
14(8):535.
PMID: 37598177
Hyperthermic intraperitoneal administration of chemotherapy (HIPEC) increases local drug concentrations and reduces systemic side effects associated with prolonged adjuvant intraperitoneal exposure in patients affected by either peritoneal malignancies or metastatic...
10.
Rago V, Di Agostino S
Antioxidants (Basel)
. 2023 Feb;
12(2).
PMID: 36829848
To date, it is known that antioxidants protect cells from damage caused by oxidative stress and associated with pathological conditions. Several studies have established that inflammation is a state that...